Skip to content
sellModerate cluster of 5

Christopher Guttman-McCabe sold $2.2M of ATEX

Chief Reg & Comm Officer at Anterix Inc.. 23,439 shares at an average of $92.36, traded Aug 25, 2026, filed Aug 27, 2026.

Warning score
50
Value
$2.2M
23,439 shares
Holdings after
44,876
-34% from before
From 52-week low
+413%
low $17.99, close $92.37
From 52-week high
-15%
high $108.21, as of Aug 25, 2026

Score components

  • Role
    Officer
    +15
  • Trade size
    $2.2M at market
    +25
  • Share of holdings sold
    Sold 34% of holdings
    +10
  • Cluster
    5 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ATEXOct 13, 2026 · close 84.87
Since filing Aug 27, 2026: -10.4%SPY +1.1% · excess -11.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001828490-26-000019, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 25, 2026MOption exercise
Common Stock
+40,000$34.72$1.4M84,876Aug 27, 2026
Aug 25, 2026FTax withholding
Common Stock
-16,561$90.38$1.5M68,315Aug 27, 2026
Aug 25, 2026SOpen-market sale
Common Stock
-5,372$93.59$503k62,943Aug 27, 2026
Aug 25, 2026SOpen-market sale
Common Stock
-7,791$92.77$723k55,152Aug 27, 2026
Aug 25, 2026SOpen-market sale
Common Stock
-7,580$91.69$695k47,572Aug 27, 2026
Aug 25, 2026SOpen-market sale
Common Stock
-2,696$90.61$244k44,876Aug 27, 2026
Aug 25, 2026MOption exercise
Stock Option (Right to Buy)derivative
-40,000$0.00$00Aug 27, 2026

Related signals

Other insiders at Anterix Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
Pro nowfree Oct 20, 2026
ATEXsell10b5-1
Anterix Inc.
Elena Marquez
Chief Financial Officer
$401k
4,981 shares
-30%
55Moderate
ATEXsell 410b5-1
Anterix Inc.
Scott A. Lang
President and CEO
$1.2M
15,000 shares
-36%
75Notable
ATEXsell 4
Anterix Inc.
Scott A. Lang
President and CEO
$1.2M
15,000 shares
-36%
42Moderate
ATEXsell 4
Anterix Inc.
Leslie B Daniels
director
$210k
2,500 shares
-5%
56Moderate
ATEXsell 4
Anterix Inc.
Heather Martin
Chief Marketing Officer
$679k
8,064 shares
-23%
40Moderate
ATEXsell 5
Anterix Inc.
Gena L Ashe
Chief Legal Officer & Corp Sec
$372k
4,357 shares
-46%
58Moderate
ATEXsell 4
Anterix Inc.
Leslie B Daniels
director
$880k
10,100 shares
-18%
55Moderate
ATEXsell 5
Anterix Inc.
Gena L Ashe
Chief Legal Officer & Corp Sec
$372k
4,357 shares
-46%
60Notable
ATEXsell 7
Anterix Inc.
Thomas R. Kuhn
director, other
$1.0M
11,654 shares
-60%
55Moderate
ATEXsell 3
Anterix Inc.
William Heard
director
$4.2M
46,400 shares
-3%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Christopher Guttman-McCabe sold $2.2M of ATEX | InsiderTell